tybost
gilead sciences ireland uc - cobicistat - hiv infektioner - antivirale midler til systemisk anvendelse - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.
viracept
roche registration ltd. - nelfinavir - hiv infektioner - antivirale midler til systemisk anvendelse - viracept er indiceret ved antiretroviral kombinationsbehandling af hiv-1-inficerede mennesker, unge og børn på tre år og ældre med humane immunsvigt. i protease-hæmmer (pi)-erfarne patienter, valg af nelfinavir bør være baseret på individuelle viral resistens test og behandling, historie.
actamone 10 mg filmovertrukne tabletter
rivopharm limited - montelukastnatrium - filmovertrukne tabletter - 10 mg
actamone 4 mg tyggetabletter
rivopharm limited - montelukastnatrium - tyggetabletter - 4 mg
actamone 5 mg tyggetabletter
rivopharm limited - montelukastnatrium - tyggetabletter - 5 mg
giona easyhaler 100 mikrogram/dosis inhalationspulver
2care4 aps - budesonid - inhalationspulver - 100 mikrogram/dosis
darunavir "sandoz" 75 mg filmovertrukne tabletter
sandoz a/s - darunavir - filmovertrukne tabletter - 75 mg
darunavir "teva" 400 mg filmovertrukne tabletter
teva b.v. - darunavirethanolat - filmovertrukne tabletter - 400 mg
darunavir "teva" 600 mg filmovertrukne tabletter
teva b.v. - darunavirethanolat - filmovertrukne tabletter - 600 mg
davarino 150 mg filmovertrukne tabletter
pharmathen s.a. - darunavirpropylenglycolat - filmovertrukne tabletter - 150 mg